Dr. Abdul Badi Abou-Samra is an academic MD/Ph.D. physician scientist certified in Internal Medicine and Endocrinology by the American Board of Internal Medicine.
He worked at several international academic institutions, which include Lyon I University, France, for five years. The National Institute of Health, Bethesda, Maryland, for two years, Harvard Medical School and the Massachusetts General Hospital for 21 years, and the Wayne State University School of Medicine for five years, where he was Professor of Medicine, Professor of Physiology, and Professor of Molecular Genetics, Chief of the endocrine division, Director of the endocrinology fellowship program and Director of a T32 endocrine research training program.
Dr. Abou-Samra received multiple recognitions for his scientific contributions and led research continuously funded by the National Institutes of Health between 1986 and 2014. He is known for his molecular and clinical research on G protein-coupled receptors, insulin action, and nutritionally-regulated genes. Dr. Abou-Samra published over 241 original papers in peer-reviewed journals and contributed to 5 USA patents. He served as a member of the NIH endocrine study section and member of the editorial board for several international journals.
Prof. Abou-Samra joined HMC in 2013 as chairman of Medicine and became the Chief Quality Officer and Deputy Chief Medical Officer in 2020. He continues to be the Director of the Qatar Metabolic Institute and Co-Chair of the Qatar National Diabetes Committee.
